Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
We also address any side effects or concerns
Injectable Wegovy produces weight loss of around 1520%+, and Zepbound (a dual GIP/GLP-1 agonist) has shown over 20% in trials
GIP Tirzepatide (brand name Zepbound for weight management and Mounjaro for type 2 diabetes) is an injectable medication that activates GLP-1 and GIP receptors
Clinical trial data shows discontinuation rates of 4-7% due to GI side effects for semaglutide, and slightly higher (6-9%) for tirzepatide, likely because higher doses are used
US$ 29.76
US$ 29.01
US$ 27.01
US$ 26.54
US$ 22.52
US$ 25.50
US$ 25.76
